Cancer Pharmacology and Stress Response Team
Dr Olivia Rossanese is the interim leader of the Cancer Pharmacology and Stress Response team. The team was previously led by Dr Vladimir Kirkin, who left the ICR in June 2020. The team assesses activity of novel molecularly targeted anti-cancer agents in preclinical models of cancer – a key requirement for evidence-based drug development.